The Roth Fellowship for CAEBV-HV Research was established in 2014 to support a two-year fellowship in the laboratory of Jeffrey I. Cohen, M.D., Chief of the Laboratory of Infectious Diseases and Chief of the Medical Virology Section at the National Institute of Allergy and Infectious Diseases (NIAID). The fellow conducts Research to accelerate efforts in finding new drugs to treat Chronic Active Epstein Barr Virus (CAEBV) (a life-threatening condition in which the body fails to properly control Epstein-Barr virus infection) and Epstein Barr Virus-Hydroa Vacciniforme (HV) (a rare skin disorder that causes blisters and scars when a person is exposed to the sun), as well as to understand genetic causes of the diseases that can lead to new treatments.)
On July 28, 2018, a meeting on basic science and clinical aspects of Hydroa Vacciniforme was held prior to the International Conference on EBV & KSHV in Madison, Wisconsin. Experts from around the world presented data on this disease and discussed future Research to better understand the virus and develop novel therapies.
Aiden Aronoff is a member of the Roth family who was diagnosed with Hydroa Vacciniforme at the age of 4. Learn more about Aiden’s story in this presentation (courtesy of Tracy Aronoff):
- National Institute of Allergy and Infectious Diseases (NIAID)
- Richard Roth*
*Provided financial or in-kind support for this program.
Please contact the Advancement Office for more information at [email protected] or 301-402-4976.